Insilico Medicine Wechat Account
18.09.2025
On September 12, 2025, the annual "50 Smartest Companies" (TR50) list by MIT Technology Review was officially unveiled in Jing'an, Shanghai. Guided by the theme of "Pushing Boundaries" and focusing on "China's Future," the list identifies and honors enterprises poised to drive technological waves in China and across the globe.
Through comprehensive analysis across multiple dimensions—including technological innovation capability, global reach, and commercialization potential—the 50 selected companies stood out. As innovative forces "In China, by China, for China," they continue to deliver transformations in technology, paradigms, and industries.
Building on its innovative practice of applying AI to drug discovery, Insilico Medicine was reselected for the list following its 2021 inclusion, garnering recognition for both its professional technological breakthroughs and commercial expansion acumen.
Disclaimer
Investment Involves risk. Past performance does not represent future performance. Investor should read the product’s Prospectus for details and risk factors before making investment decision. The contents of this website is prepared and maintained by Mirae Asset Capital (China) Limited. This material has not been reviewed by the Securities and Futures Commission. Certain information contained in this website is compiled from third party sources. Whilst we have, to the best of its endeavor, ensured that such, information is accurate, complete and up-to-date, and has taken care in accurately reproducing the information. We accepts no liability for, any loss or damage of any kind resulting out of the unauthorized use of this website.
Sep 28, 2025
